Holen Sie sich die Stockscreener-App
16.14
12.32%
1.77
Vorhandelsmarkt:
16.34
0.20
+1.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Kenvue Stock Rose 12% On Possible $48.7 Billion Acquisition by Kimberly-Clark - TIKR.com
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn - Pharmaceutical Technology
Levin Capital Strategies L.P. Buys New Shares in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Sold by Bank of New York Mellon Corp - MarketBeat
Kenvue Inc. $KVUE Stake Reduced by South Dakota Investment Council - MarketBeat
Kenvue: Q3 Earnings Snapshot - New Haven Register
Kimberly-Clark Stock Drops Premarket Even As Analysts, Retail Investors Turn Positive On $49B Kenvue Deal - Stocktwits
Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal - NPR
Is now a turning point for Kenvue Inc.Quarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Real time scanner hits for Kenvue Inc. explainedForecast Cut & AI Forecast Swing Trade Picks - newser.com
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors? - AOL.com
Predicting Kenvue Inc. trend using moving averages2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
21,714 Shares in Kenvue Inc. $KVUE Acquired by World Investment Advisors - MarketBeat
Order flow analysis tools used on Kenvue Inc.2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
What Next for Kenvue’s Beauty Brands? - The Business of Fashion
Kenvue Fails To Deliver After Launch Expected To Drive Iconic Brands To New Heights - Citeline News & Insights
Decoding Kenvue Inc (KVUE): A Strategic SWOT Insight - GuruFocus
Kimberly-Clark is taking Tylenol in $49 billion deal - Morning Brew
Kenvue’s Tylenol Litigation Overhang Doesn’t Dim ‘Generational Opportunity’ For Kimberly-Clark - Citeline News & Insights
Tylenol maker Kenvue secures deal from consumer goods giant - Yahoo Finance
Latham Advises on Financing for Kimberly-Clark’s Acquisition of Kenvue to Create a US$32 Billion Global Health and Wellness Leader - Legal Desire Media and Insights
Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal - WQOW
Why Tylenol Maker Kenvue Stock Just Popped - AOL.com
Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc.KVUE - The AI Journal
Buy Rating on Kenvue, Inc.: Promising Investment Amid Acquisition and Legal Challenges - TipRanks
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient' - CNBC
Kimberly-Clark to Acquire Kenvue - WWD
North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal - Dallas Innovates
Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark - Yahoo Finance
With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm - The New York Times
Factbox-Kenvue’s Legal Risks Loom Over Planned Acquisition by Kimberly-Clark - US News Money
Kimberly-Clark acquires Neutrogena-owner Kenvue - FashionNetwork USA
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - The Wall Street Journal
Markets News, Nov. 3, 2025: Dow Falters as Cloud Deals Boost Nasdaq; Kenvue Stock Soars on Kimberly-Clark Takeover - Investopedia
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Kenvue Inc. - 富途牛牛
Kenvue: Takeover by Kimberly-Clark Gives Shareholders a Lifeline - Morningstar
Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith - Yahoo Finance
Reports of ‘Click-to-Cancel’s Death May Be Premature - PYMNTS.com
Kenvue, Kimberly-Clark, Amazon, uniQure, Palantir, Idexx, Cipher Mining, and More Movers - Barron's
S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue - Investopedia
Kenvue To Be Acquired by Kimberly-Clark To Create a Personal Care Giant - Morningstar
Kimberly-Clark to Buy Tylenol Maker Kenvue. Why KMB Stock Is Tanking. - Barron's
Dear Kenvue Stock Fans, Mark Your Calendars for November 6 Upcoming earnings - Barchart.com
That $40 Billion Tylenol Deal Is Both Cheap and Risky - Bloomberg.com
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - CBS 42
Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion - Bloomberg.com
The Key Question Around The Kenvue/Kimberly-Clark Tie-Up (NYSE:KVUE) - Seeking Alpha
Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy - MSN
Kenvue jumps after Kimberly‑Clark announces $48.7B acquisition - Quiver Quantitative
Kenvue could see interest from other suitorsanalyst (KVUE:NYSE) - Seeking Alpha
Kimberly-Clark buying Tylenol-maker Kenvue in cash, stock deal worth about $48.7B - ABC7 Chicago
Huggies maker Kimberly-Clark is buying Tylenol maker KenvueOregon Public Broadcasting - Oregon Public Broadcasting - OPB
Irving-based Kimberly-Clark buys Tylenol maker Kenvue in $48.7 billion deal - Dallas News
Kimberly-Clark to buy Kenvue for $40 billion - Ad Age
Kimberly-Clark buys Tylenol-maker Kenvue in $48.7 billion deal - The Spokesman-Review
How Tylenol Owner’s Short Stint as a Public Company Ended - Bloomberg.com
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn - Al Jazeera
Kenvue Stock Pops on News Kimberly-Clark Will Buy It for $48.7B. Is It Too Late to Buy KVUE Here? - Yahoo Finance
Kimberly-Clark, parent company of Kleenex and Huggies, buys the maker of Tylenol in $48.7 billion deal. What you need to know - Yahoo Finance
Kimberly-Clark makes a $49 billion bet that Tylenol risk is overblown - Yahoo Finance
Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger - Yahoo Finance
Kenvue Inc. Reaffirms Earnings Guidance for the Full Year 2025 - MarketScreener
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday - Benzinga
Kimberly-Clark bets $40 billion on Kenvue despite Tylenol controversy - Yahoo Finance
Is Kenvue’s Stock Ready for a Rebound? - StocksToTrade
Kimberly-Clark to Acquire Tylenol Maker Kenvue in $49 Billion Deal - D Magazine
Kimberly-Clark to Acquire Kenvue in US$48.7 Billion Merger - Mexico Business News
What is Kenvue? What to know about the maker of Tylenol acquired by Kimberly-Clark - Dallas News
Kenvue Acquisition Boosts Kimberly-Clark Growth; Mahoning Valley Philanthropists to Be Honored - Business Journal Daily
14.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):